zumantu, Agree 100%! Time is so critically important here. If there were any substantiated benefit from Vascepa with COVID-19 or its after effects, BP would acquire AMRN and tie up all raw material feed stock to choke off any possibility of generic threat. BP can do that...AMRN cannot!